FDA approves breakthrough drug to treat advanced pancreatic cancer
(WASHINGTON) -- The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer.The drug, called daraxonrasib, will be sold under the brand name Rasonque from Revolution Medicines. The daily pill targets multiple forms of a protein called RAS, which is a main driver of tumor growth.A late-stage clinical trial with 500 patients showed that the median overall survival nearly doubled to […]
